Osteoclast mediated bone destruction in collagen-induced arthritis is revealed by targeting the RANKL-RANK interaction with osteoprotegerin

被引：0
|
作者：
Romas, E
Sims, NA
Quinn, JMW
Dunstan, CR
Martin, TJ
Gillespie, MT
机构：
[1] Univ Melbourne, St Vincents Hosp, Melbourne, Vic, Australia
[2] St Vincents Inst Med Res, Melbourne, Vic, Australia
[3] Amgen Inc, Thousand Oaks, CA USA
来源：
BONE | 2003年 / 32卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [1] Triptolide Prevents Bone Destruction in the Collagen-Induced Arthritis Model of Rheumatoid Arthritis by Targeting RANKL/RANK/OPG Signal Pathway
    Liu, Chunfang
    Zhang, Yanqiong
    Kong, Xiangying
    Zhu, Liuluan
    Pang, Jian
    Xu, Ying
    Chen, Weiheng
    Zhan, Hongsheng
    Lu, Aiping
    Lin, Na
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
  • [2] Regulation of bone destruction in rheumatoid arthritis through RANKL-RANK pathways
    Tanaka, Sakae
    WORLD JOURNAL OF ORTHOPEDICS, 2013, 4 (01): : 1 - 6
  • [3] Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis
    Romas, E
    Sims, NA
    Hards, DK
    Lindsay, M
    Quinn, JWM
    Ryan, PFJ
    Dunstan, CR
    Martin, TJ
    Gillespie, MT
    AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (04): : 1419 - 1427
  • [4] Triptolide protects bone against destruction by targeting RANKL-mediated ERK/AKT signalling pathway in the collagen-induced rheumatoid arthritis.
    Gong, Yan
    Huang, Xiaopeng
    Wang, Di
    Li, Ming
    Liu, Zhongyuan
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (09): : 4111 - 4116
  • [5] Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritis
    Sims, NA
    Green, JR
    Glatt, M
    Schlict, S
    Martin, TJ
    Gillespie, MT
    Romas, E
    ARTHRITIS AND RHEUMATISM, 2004, 50 (07): : 2338 - 2346
  • [6] Xuetongsu attenuates bone destruction in collagen-induced arthritis mice by inhibiting osteoclast differentiation and promoting osteoclast apoptosis
    Zheng, Hao
    Li, Yunzhe
    Deng, Yasi
    Li, Huanjie
    Shen, Xinyang
    Lin, Haokai
    Yang, Yong
    Tian, Xing
    Li, Bin
    Yuan, Hanwen
    Sheng, Wenbing
    Wang, Wei
    Yu, Huanghe
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2024, 169
  • [7] Small molecule stimulators of osteoprotegerin secretion inhibits bone destruction in collagen-induced arthritis models.
    Sung, H.
    Park, I.
    Lee, J.
    Kwon, J.
    Kim, T.
    Kim, H.
    Ko, S.
    Shim, S.
    Kim, S.
    Chang, S.
    Kim, J.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S119 - S119
  • [8] Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritis.
    Sims, NA
    Green, JR
    Martin, TJ
    Gillespie, MT
    Romas, E
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S147 - S147
  • [9] Fc-osteoprotegerin fusion protein (Fc-OPG) reduces osteoclast numbers and prevents bone destruction in rats with collagen-induced arthritis.
    Romas, E
    Sims, NA
    Hards, D
    Lindsay, M
    Ryan, PFJ
    Quinn, JA
    Dunstan, C
    Martin, TJ
    Gillespie, MT
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S267 - S267
  • [10] Fc-osteoprotegerin (Fc-OPG) fusion protein reduces osteoclast numbers and prevents bone destruction in rats with collagen-induced arthritis.
    Romas, E
    Sims, NA
    Hards, D
    Lindsay, M
    Ryan, PFJ
    Quinn, JMW
    Dunstan, C
    Martin, TJ
    Gillespie, MT
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S270 - S270
12345